KELLEY JACOBS: Open Payments
NPI 1952721672 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 44 payments from 22 companies in 2025. Trend: 2023 $813 · 2024 $796 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $90 |
| ABBVIE INC. | 4 | $84 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Forte Bio-Pharma LLC | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: Korlym, XIFAXAN, PROLATE, JARDIANCE, TRELEGY ELLIPTA, UBRELVY, Cologuard Collection Kit, LEQVIO.
Industry payments across SC — which companies pay providers there.
